SCHEMBL4900979

SCHEMBL4900979

CCN(c1nc(-c2ccccc2)oc1C)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
LMNA P02545 3/20 0.42
ALDH1A1 P00352 6/20 0.42
HSD17B10 Q99714 4/20 0.42
HPGD P15428 4/20 0.42
KDM4E B2RXH2 4/20 0.42
TSHR P16473 1/20 0.41
TARBP2 Q15633 1/20 0.41
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
ALOX15 P16050 1/20 0.40
ESR1 P03372 1/20 0.40
HTT P42858 1/20 0.40
USP2 O75604 1/20 0.38
TOP2A P11388 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899907 0.92 LMNA (0.41) SMN1; SMN2KMT2ALMNAALDH1A1HSD17B10
SCHEMBL4904182 0.91 LMNA (0.48) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL4905062 0.91 ALDH1A1 (0.42) SMN1; SMN2LMNAALDH1A1HSD17B10HPGD
SCHEMBL4906795 0.90 TARBP2 (0.41) SMN1; SMN2KMT2ALMNAALDH1A1HSD17B10
SCHEMBL4904572 0.89 PPARG (0.44) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL4903604 0.84 LMNA (0.47) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL4905178 0.83 PTPN1 (0.47) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL4905884 0.83 LMNA (0.46) KMT2ANPC1RAB9ALMNAALDH1A1
SCHEMBL4904123 0.82 LMNA (0.43) KMT2ALMNAALDH1A1HSD17B10HPGD
SCHEMBL4904506 0.81 LMNA (0.40) KMT2ALMNAALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD SMN1; SMN2 3271/4885KMT2A 3602/4885MEN1 4859/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD SMN1; SMN2 3404/4885KMT2A 3530/4885MEN1 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.